https://www.selleckchem.com/pr....oducts/voxtalisib-xl
845 vs 0.819, P=0.012), ACEF (AUC 0.845 vs 0.827, P=0.014), C-ACS (AUC 0.845 vs 0.767, P less then 0.001). In patients with non-ST segment-elevation acute coronary syndrome (NSTE-ACS), there was no statistically significant difference between the GRACE risk scale and AGEF (AUC 0.853 vs 0.832, P=0.14 for in-hospital death. CONCLUSIONS AGEF risk score showed a non-inferior utility compared with the other 3 scoring systems in estimating in-hospital mortality in ACS patients.BACKGROUND Preeclampsia is a common complicat
Beğen
Yorum Yap
Paylaş
